Kai Wang1, Xuanren Pan, Qiaoyun Tang, Yusheng Pang. 1. Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Autonomous Region, China.
Abstract
BACKGROUND: Patent ductus arteriosus (PDA) remains a common congenital heart disease in pediatric patients, and the new trend of catheterization therapy is still associated with some potential risks and complications. HYPOTHESIS: Compared with surgical closure, the clinical effect of catheterization therapy in pediatric PDA patients requires meta-analysis. METHODS: A systematic literature search of PubMed, Cochrane Library, Embase, Science Citation Index, Web of Science, and the Chinese Biomedicine literature database was conducted. Eligible studies included controlled trials of pediatric PDA patients receiving catheterization therapy vs surgical closure. Relative risks (RRs), standard mean differences, and 95% confidence intervals (CIs) were calculated and heterogeneity was assessed with the I(2) test. RESULTS: Seven studies with a total of 810 patients met the inclusion criteria. Catheterization therapy neither significantly increased the primary success rate (RR: 0.92, 95% CI: 0.82-1.03, P = 0.16) nor reduced the total postprocedure complications (RR: 0.74, 95% CI: 0.44-1.25, P = 0.26) and blood transfusion (RR: 1.10, 95% CI: 0.16-7.67, P = 0.93). Catheterization was associated with a statistically significant increase in residual shunts (RR: 5.19, 95% CI: 1.41-19.20, P = 0.01) and reduction in length of hospital stay (standard mean difference: -1.66, 95% CI: -2.65 to -0.67, P = 0.001). CONCLUSIONS: Catheterization therapy in pediatric PDA patients did not show a significant advantage in primary success rate, total complications, or blood transfusion, but it was associated with increase in residual shunts and reduction in length of hospital stay.
BACKGROUND:Patent ductus arteriosus (PDA) remains a common congenital heart disease in pediatric patients, and the new trend of catheterization therapy is still associated with some potential risks and complications. HYPOTHESIS: Compared with surgical closure, the clinical effect of catheterization therapy in pediatric PDA patients requires meta-analysis. METHODS: A systematic literature search of PubMed, Cochrane Library, Embase, Science Citation Index, Web of Science, and the Chinese Biomedicine literature database was conducted. Eligible studies included controlled trials of pediatric PDA patients receiving catheterization therapy vs surgical closure. Relative risks (RRs), standard mean differences, and 95% confidence intervals (CIs) were calculated and heterogeneity was assessed with the I(2) test. RESULTS: Seven studies with a total of 810 patients met the inclusion criteria. Catheterization therapy neither significantly increased the primary success rate (RR: 0.92, 95% CI: 0.82-1.03, P = 0.16) nor reduced the total postprocedure complications (RR: 0.74, 95% CI: 0.44-1.25, P = 0.26) and blood transfusion (RR: 1.10, 95% CI: 0.16-7.67, P = 0.93). Catheterization was associated with a statistically significant increase in residual shunts (RR: 5.19, 95% CI: 1.41-19.20, P = 0.01) and reduction in length of hospital stay (standard mean difference: -1.66, 95% CI: -2.65 to -0.67, P = 0.001). CONCLUSIONS: Catheterization therapy in pediatric PDA patients did not show a significant advantage in primary success rate, total complications, or blood transfusion, but it was associated with increase in residual shunts and reduction in length of hospital stay.
Authors: Arash Salavitabar; Usha S Krishnan; Mariel E Turner; Julie A Vincent; Alejandro J Torres; Matthew A Crystal Journal: Tex Heart Inst J Date: 2020-08-01
Authors: Tomasz Stankowski; Sleiman Sebastian Aboul-Hassan; Dirk Fritzsche; Marcin Misterski; Jakub Marczak; Anna Szymańska; Katarzyna Wijatkowska; Cyprian Augustyn; Romuald Cichoń; Bartłomiej Perek Journal: Kardiochir Torakochirurgia Pol Date: 2018-06-25
Authors: Michael T Kuntz; Steven J Staffa; Dionne Graham; David Faraoni; Philip Levy; James DiNardo; Nicola Maschietto; Viviane G Nasr Journal: J Am Heart Assoc Date: 2021-12-31 Impact factor: 6.106
Authors: Tomasz Stankowski; Sleiman Sebastian Aboul-Hassan; Farzaneh Seifi-Zinab; Dirk Fritzsche; Marcin Misterski; Ivan Sazdovski; Jakub Marczak; Anna Szymańska; Lukasz Szarpak; Kurt Ruetzler; Sanchit Ahuja; Bartłomiej Perek Journal: J Thorac Dis Date: 2019-06 Impact factor: 2.895